Patents by Inventor Daniel W. Goodman

Daniel W. Goodman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11497545
    Abstract: An end effector of an electrosurgical forceps includes a first jaw member, a second jaw member, and a cap. The first jaw member has a pivot pin extending inwardly from an inner lateral side thereof. The second jaw member is pivotably coupled to the pivot pin. The cap couples the first and second jaw members to one another.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: November 15, 2022
    Assignee: Covidien LP
    Inventors: Grant T. Sims, Kelley D. Goodman, Craig V. Krastins, Robert F. McCullough, Jr., Jennifer L. Rich, Daniel W. Mercier
  • Publication number: 20220331004
    Abstract: An electrosurgical forceps includes first and second shaft members and first and second jaw members extending distally from the respective first and second shaft members. A pivot couples the first and second shaft members with one another such that the first and second shaft members are movable relative to one another between a spaced-apart position and an approximated position to move the first and second jaw members relative to one another between an open position and a closed position. The jaw members are configured to facilitate tissue treatment, tissue division, and blunt tissue dissection.
    Type: Application
    Filed: July 1, 2022
    Publication date: October 20, 2022
    Inventors: Grant T. Sims, Benjamin R. Arts, Kelley D. Goodman, David M. Keffeler, Craig V. Krastins, Robert F. McCullough, Jr., Daniel W. Mercier, Jennifer L. Rich
  • Patent number: 11471211
    Abstract: An electrosurgical forceps includes first and second shaft members and first and second jaw members extending distally from the respective first and second shaft members. A pivot couples the first and second shaft members with one another such that the first and second shaft members are movable relative to one another between a spaced-apart position and an approximated position to move the first and second jaw members relative to one another between an open position and a closed position. The jaw members are configured to facilitate tissue treatment, tissue division, and blunt tissue dissection.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: October 18, 2022
    Assignee: Covidien LP
    Inventors: Grant T. Sims, Benjamin R. Arts, Kelley D. Goodman, David M. Keffeler, Craig V. Krastins, Robert F. Mccullough, Jr., Daniel W. Mercier, Jennifer L. Rich
  • Patent number: 11419665
    Abstract: An electrosurgical forceps includes a pair of first and second shaft members pivotably coupled to one another, an end effector assembly coupled to the pair of first and second shaft members, a knife selectively translatable through the first shaft member and the end effector assembly, and a knife deployment mechanism. The second shaft member has a flange extending therefrom toward the first shaft member. The knife deployment mechanism includes a distal extension movably coupled to the first shaft member and configured to engage the flange of the second shaft member when the knife is an extended position and the end effector assembly is in a closed configuration. The engagement between the distal extension and the flange resists movement of the end effector assembly from the closed configuration.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: August 23, 2022
    Assignee: Covidien LP
    Inventors: Daniel W. Mercier, Kelley D. Goodman, Craig V. Krastins, Robert F. Mccullough, Jr., Jennifer L. Rich, Grant T. Sims
  • Publication number: 20220257304
    Abstract: A coupling for an electrosurgical cable of a surgical instrument includes insulative contact collars arranged in a stack-like manner, each contact collar having a flange supporting a contact ring thereon. The contact rings configured for electrical engagement with electrical leads of the electrosurgical cable. Contact wires configured to engage corresponding contact rings at one end and a jumper wire at the other end thereof, the jumper wires, in turn, couple to an activation switch of the surgical instrument. A locking bobbin envelops the contact collars to lock contact wires in secure engagement with the contact rings. The locking bobbin locks within the surgical instrument preventing the contact wires from rotating within the surgical instrument while permitting the contact collars, the contact rings and the electrosurgical cable to rotate relative to the surgical instrument.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 18, 2022
    Inventors: Kelley D. Goodman, Craig V. Krastins, Jennifer L. Rich, Riley A. Pepia, Grant T. Sims, Daniel W. Mercier
  • Patent number: 11382685
    Abstract: An electrosurgical forceps includes a pair of first and second shaft members pivotably coupled to one another, an end effector assembly coupled to the pair of first and second shaft members, and a resilient, compressible pivot assembly pivotably coupling the first and second shaft members to one another.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: July 12, 2022
    Assignee: Covidien LP
    Inventors: Grant T. Sims, Daniel W. Mercier, Craig V. Krastins, Jennifer L. Rich, Kelley D. Goodman
  • Patent number: 11376062
    Abstract: An electrosurgical forceps includes first and second shaft members and first and second jaw members extending distally from the respective first and second shaft members. A pivot couples the first and second shaft members with one another such that the first and second shaft members are movable relative to one another between a spaced-apart position and an approximated position to move the first and second jaw members relative to one another between an open position and a closed position. The jaw members are configured to facilitate tissue treatment, tissue division, and blunt tissue dissection.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: July 5, 2022
    Assignee: COVIDIEN LP
    Inventors: Grant T. Sims, Benjamin R. Arts, Kelley D. Goodman, David M. Keffeler, Craig V. Krastins, Robert F. McCullough, Jr., Daniel W. Mercier, Jennifer L. Rich
  • Publication number: 20120070494
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: August 16, 2011
    Publication date: March 22, 2012
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Publication number: 20110008425
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: September 20, 2010
    Publication date: January 13, 2011
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Patent number: 7595341
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: September 29, 2009
    Assignees: Resolvyx Pharmacuticals, Inc., The Brigham and Women's Hospital
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Patent number: 7557109
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: July 7, 2009
    Assignee: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Publication number: 20090104261
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: December 24, 2008
    Publication date: April 23, 2009
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Patent number: 7504395
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: March 17, 2009
    Assignee: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Publication number: 20080207753
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 28, 2008
    Applicants: Resolvyx Pharmaceuticals, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Patent number: 7378444
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: May 27, 2008
    Assignees: Brigham and Women's Hospital, Inc., Resolvyx Pharmaceuticals, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Publication number: 20040044050
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 &ohgr;-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 4, 2004
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten
  • Publication number: 20030050308
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: July 19, 2002
    Publication date: March 13, 2003
    Inventors: Daniela Brunner, Daniel W. Goodman